(Total Views: 651)
Posted On: 08/06/2020 9:42:59 AM
Post# of 149272
Re: Rubraquercus #47422
“RLFTF FDA grants inhaled use IND for RLF-100 (aviptadil) to treat patients with moderate and severe COVID-19
FDA has moved at lightning speed on this, I expect no less for leronlimb.”
Just an FYI, CYDY had their COVID INDs approved 4-5 months ago and the drug is far ahead of RLF-100.
FDA has moved at lightning speed on this, I expect no less for leronlimb.”
Just an FYI, CYDY had their COVID INDs approved 4-5 months ago and the drug is far ahead of RLF-100.
(0)
(1)Scroll down for more posts ▼
